Source comparison
TB-500 vs BPC-157: Comparison for Tissue Repair
TB-500 Upregulates actin, promotes angiogenesis and cell migration 2–2.5mg Twice weekly 4–6 weeks Chronic tendon injuries, deep tissue damage, systemic healing Slower onset but stronger for structural tissue repair. Ideal for injuries that haven't responded to
This comparison does not assign a generated winner or score.
- TB-500
- Upregulates actin, promotes angiogenesis and cell migration
- 2–2.5mg
- Twice weekly
- 4–6 weeks
- Chronic tendon injuries, deep tissue damage, systemic healing
- Slower onset but stronger for structural tissue repair. Ideal for injuries that haven't responded to other interventions
- BPC-157
- Stabilises nitric oxide pathways, accelerates fibroblast activity
- 250–500mcg
- Daily
- 1–3 weeks
- Acute muscle strains, gut inflammation, ligament injuries
- Faster subjective improvement, particularly in soft tissue injuries and GI issues. Often stacked with TB-500 for synergistic effect
- Combined Protocol
- Complementary pathways (angiogenesis + fibroblast activation)
- TB-500 2mg twice weekly + BPC-157 500mcg daily
- Varies by compound
- 2–4 weeks
- Complex injuries requiring both vascular repair and connective tissue regeneration
- Most researchers see better outcomes stacking both. BPC provides early symptom relief while TB-500 handles deeper structural repair
- TB-500 and BPC-157 are not interchangeable. TB-500 excels at promoting new blood vessel growth in areas with poor vascular supply. Chronic tendon issues, old injuries that never fully healed. BPC-157 works faster on acute injuries by accelerating fibroblast migration and collagen synthesis. Many research protocols combine both: BPC-157 for immediate tissue stabilisation, TB-500 for long-term vascular remodelling.